SCHEMBL21146944

SCHEMBL21146944

c1ccc(-c2cc(-c3nc(-c4cccc(-n5c6ccccc6c6ccccc65)c4)nc(-c4ccc(-c5ccccc5)c(-n5c6ccccc6c6ccccc65)c4)n3)ccc2-n2c3ccccc3c3ccccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
KMT2A Q03164 3/20 0.33
GAA P10253 2/20 0.33
MEN1 O00255 2/20 0.33
PDE10A Q9Y233 1/20 0.33
ACP1 P24666 2/20 0.32
ALDH1A1 P00352 3/20 0.32
PLA2G10 O15496 1/20 0.32
IL1R1 P14778 1/20 0.32
ABCG2 Q9UNQ0 2/20 0.31
TSHR P16473 1/20 0.31
LMNA P02545 1/20 0.31
FOLH1 Q04609 1/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21147167 0.96 KDM4E (0.42) L3MBTL1KDM4EATMKMT2AGAA
SCHEMBL21147845 0.95 KDM4E (0.41) L3MBTL1KDM4EATMKMT2AGAA
SCHEMBL21147262 0.95 KDM4E (0.46) L3MBTL1KDM4EATMKMT2AGAA
SCHEMBL21147321 0.94 ATM (0.41) L3MBTL1KDM4EATMKMT2AGAA
SCHEMBL21147799 0.94 ATM (0.41) L3MBTL1KDM4EATMKMT2AGAA
SCHEMBL21146942 0.94 ATM (0.41) L3MBTL1KDM4EATMKMT2AGAA
SCHEMBL21147836 0.94 ATM (0.41) L3MBTL1KDM4EATMKMT2AGAA
SCHEMBL21147170 0.94 ATM (0.41) L3MBTL1KDM4EATMKMT2AGAA
SCHEMBL21147223 0.94 ATM (0.41) L3MBTL1KDM4EATMKMT2AGAA
SCHEMBL21147159 0.94 KDM4E (0.45) L3MBTL1KDM4EATMKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11706977-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-18 US disclosed
US-11706977-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-18 US disclosed
US-20200212314-A1 ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-07-02 US disclosed
EP-3675194-A1 ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME Samsung Electronics Co., Ltd. (KR) 2020-07-01 EP disclosed
US-20190214570-A1 HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11706977-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CRY1, CYP1B1, CYP1A1 L3MBTL1 1990/4885KDM4E 2739/4885ATM 2932/4885
US-20190214570-A1 HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND CRY1, CYP1B1, CYP1A1 L3MBTL1 1990/4885KDM4E 2739/4885ATM 2932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.